Beijing Increasepharm Safety and Efficacy
Co., Ltd. is the pre-evaluation section of pharmacodynamic and pharmacokinetic safety of Increasepharm
new drug R&D, which can provide research services such as new drug pharmacodynamics, pharmacokinetic research and
various safety pre-evaluation for self-research and external projects.
We have established a standardized pharmacodynamic and pharmacokinetic research
platform that meets GLP requirements, and can perform preclinical drug
screening evaluation and pharmacodynamic and pharmacokinetic research. We are able to carry out
drug screening and evaluation, druggability research, mechanism research and
registration of chemical and TCM, including enzymatic, cellular, animal-level
overall pharmacodynamic and pharmacokinetic evaluation, and cooperate with CRO for toxicology research.
Aerosol inhalation research platform and new drug screening research platform are two special research platforms of pharmacology and toxicology research center.
Scan the WeChat QR code